eIF4G1 inhibitor

DRUG CLASS:

News alerts, weekly reports and conference planners

Related drugs:

‹

›

NRAS Q61K	Melanoma	NRAS Q61K	Melanoma	SBI-756 Sensitive: D – Preclinical SBI-756 Sensitive : D	SBI-756 Sensitive: D – Preclinical SBI-756 Sensitive : D
NRAS mutation	Melanoma	NRAS mutation	Melanoma	SBI-726 Sensitive: D – Preclinical SBI-726 Sensitive : D	SBI-726 Sensitive: D – Preclinical SBI-726 Sensitive : D
BCR-ABL1 fusion	B Acute Lymphoblastic Leukemia	BCR-ABL1 fusion	B Acute Lymphoblastic Leukemia	dasatinib + SBI-756 Sensitive: D – Preclinical dasatinib + SBI-756 Sensitive : D	dasatinib + SBI-756 Sensitive: D – Preclinical dasatinib + SBI-756 Sensitive : D

Associations(3)